Dunad Therapeutics

Dunad Therapeutics is a private, early-stage biotech company developing novel medicines using a proprietary tunable covalent chemistry platform. The company faced challenges aligning its foundational story with its evolving science, further complicated by company restructuring and a pitch deck that did not reflect its current direction.

Referred to us by another client, the Dunad team came to Theoria Creative for help repositioning their narrative and updating their branding. Our work included clarifying the company’s core message, developing a compelling story, designing a new brand identity that emphasizes their covalent approach, and building a focused pitch deck that included mechanism-of-action illustrations. 

The result was a cohesive, forward-looking identity and narrative that shifted the company’s positioning from a platform-focused story to one centered on a differentiated asset, giving them a clearer competitive edge in the market.